Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
52
Frequently Asked Questions
What is Market Cap of Bolt Biotherapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bolt Biotherapeutics Inc market cap is $9.96M.
What is the 52-week high for Bolt Biotherapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bolt Biotherapeutics Inc 52 week high is $14.36 as of September 08, 2025.
What is the 52-week low for Bolt Biotherapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bolt Biotherapeutics Inc 52 week low is $4.59 as of September 08, 2025.
What is Bolt Biotherapeutics Inc stock price today?
Bolt Biotherapeutics Inc stock price today is $5.13.
What was Bolt Biotherapeutics Inc stock price yesterday?
Bolt Biotherapeutics Inc stock price yesterday was $5.19.
What is the PE ratio of Bolt Biotherapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bolt Biotherapeutics Inc’s P/E ratio is -0.20.
What is the Price-to-Book ratio of Bolt Biotherapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Bolt Biotherapeutics Inc P/B ratio is 0.2565.
What is the 50-day moving average of Bolt Biotherapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bolt Biotherapeutics Inc 50-day moving average is $5.63.
How many employess does Bolt Biotherapeutics Inc has?